Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Forearm Muscle and Tendon Thickness in Rotator Cuff-Related Shoulder Pain

17 giugno 2026 aggiornato da: Ömer Faruk ÖZÇELEP, Kirsehir Ahi Evran Universitesi

Ultrasonographic Assessment of Forearm Muscle and Tendon Thickness According to Symptom Duration in Individuals With Rotator Cuff-Related Shoulder Pain

Rotator cuff-related shoulder pain (RCRSP) is one of the most common musculoskeletal disorders affecting the shoulder and is frequently associated with pain, reduced muscle strength, and impaired upper extremity function. Although previous studies have primarily focused on structural and functional changes around the shoulder, little is known about the potential adaptations occurring in the distal upper extremity, particularly the forearm muscles and tendons.

Altered upper extremity use, pain-related muscle inhibition, and compensatory movement patterns associated with prolonged shoulder pain may lead to morphological changes in the forearm musculature and tendons. However, the relationship between symptom duration and these structural adaptations has not yet been investigated.

The aim of this cross-sectional study is to evaluate forearm muscle and tendon thickness using portable ultrasonography in individuals with RCRSP and to investigate whether these parameters differ according to symptom duration. In addition, hand grip strength, pain intensity, and upper extremity function will be assessed to explore their associations with ultrasonographic findings.

The findings of this study are expected to provide new insights into distal upper extremity adaptations associated with RCRSP and may contribute to the development of more comprehensive rehabilitation strategies that address not only the shoulder but also the forearm musculature.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Descrizione dettagliata

Rotator cuff-related shoulder pain (RCRSP) is one of the leading causes of shoulder pain and disability in adults. In addition to local impairments such as pain, muscle weakness, and reduced range of motion, individuals with RCRSP frequently demonstrate altered upper extremity movement patterns and reduced functional performance. These adaptations may extend beyond the shoulder joint and influence distal segments of the upper extremity.

Previous research has primarily focused on structural changes in the rotator cuff muscles and tendons, scapular musculature, and shoulder biomechanics. However, the potential morphological adaptations of the forearm muscles and tendons remain largely unexplored. Persistent pain, reduced upper limb use, altered neuromuscular control, and compensatory motor strategies associated with prolonged shoulder symptoms may contribute to changes in forearm muscle and tendon morphology. Understanding these adaptations may improve the current understanding of the regional effects of RCRSP.

Musculoskeletal ultrasonography provides a valid, reliable, non-invasive, and accessible method for evaluating muscle and tendon morphology. The increasing availability of portable ultrasound devices has expanded the feasibility of assessing musculoskeletal structures in both clinical and research settings. Despite these advantages, ultrasonographic evaluation of forearm muscles and tendons has rarely been performed in individuals with RCRSP.

This cross-sectional study aims to investigate the association between symptom duration and forearm muscle and tendon thickness measured by portable ultrasonography in individuals with RCRSP. The study also seeks to explore whether structural changes in the forearm are accompanied by alterations in hand grip strength, pain intensity, and upper extremity function. The findings may contribute to a better understanding of distal musculoskeletal adaptations associated with prolonged shoulder pain and provide evidence for incorporating forearm assessment into rehabilitation programs for individuals with RCRSP.

Tipo di studio

Osservativo

Iscrizione (Stimato)

90

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

### Study Population Description

The study population will consist of adult individuals aged 18-65 years, including both patients with rotator cuff-related shoulder pain (RCRSP) and healthy control participants. Participants with RCRSP will be recruited based on clinical diagnosis confirmed by physical examination and positive clinical tests consistent with rotator cuff-related shoulder pain. Healthy controls will be recruited from the community and hospital staff and will have no history of shoulder pain or upper extremity musculoskeletal disorders.

Patients with RCRSP will be further categorized according to symptom duration into subgroups for comparative analysis. All participants will undergo a single assessment session including ultrasonographic evaluation of forearm muscle and tendon thickness, hand grip strength measurement, and standardized functional and pain assessments.

Participants will be recruited from outpatient physiotherapy and orthopedic clinics of the participatin

Descrizione

Inclusion Criteria:

RCRSP Group Adults aged 18-65 years. Clinical diagnosis of rotator cuff-related shoulder pain (RCRSP). Unilateral shoulder pain lasting at least 6 weeks. Pain localized around the anterolateral shoulder, aggravated by arm elevation and/or overhead activities.

Positive findings on at least three clinical tests suggestive of RCRSP (e.g., painful arc, Hawkins-Kennedy test, Neer test, Jobe/Empty Can test, resisted external rotation).

Ability to understand the study procedures and provide written informed consent.

Healthy Control Group Adults aged 18-65 years. No current shoulder pain. No history of shoulder pain, shoulder surgery, or upper extremity musculoskeletal disorders during the previous 12 months.

Ability to provide written informed consent.

Exclusion Criteria:

Previous shoulder surgery on either upper extremity. History of shoulder fracture, shoulder dislocation, or major upper extremity trauma.

Full-thickness rotator cuff tear or other shoulder pathology requiring surgical management.

Clinical signs of adhesive capsulitis. Cervical radiculopathy or other neurological disorders affecting the upper extremity.

Systemic inflammatory, rheumatologic, or neuromuscular diseases. Peripheral nerve entrapment (e.g., carpal tunnel syndrome, cubital tunnel syndrome).

Previous surgery or significant injury involving the forearm, wrist, or hand. Corticosteroid injection into the affected shoulder within the previous 3 months.

Current pregnancy. Inability to complete study assessments or provide informed consent.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Healthy Controls
Healthy individuals without shoulder pain or a history of shoulder pathology, matched to the patient groups by age and sex where possible.
Short-Duration RCRSP
Participants diagnosed with rotator cuff-related shoulder pain with symptom duration of less than 6 months.
Long-Duration RCRSP
Participants diagnosed with rotator cuff-related shoulder pain with symptom duration of 6 months or longer.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Forearm Muscle and Tendon Thickness
Lasso di tempo: Baseline (single assessment)
Forearm muscle and tendon thickness will be measured using portable B-mode ultrasonography. Measurements will be obtained from standardized anatomical landmarks with participants in a standardized position. The thickness (mm) of selected forearm flexor and extensor muscles and tendons will be recorded and compared between healthy controls and participants with rotator cuff-related shoulder pain according to symptom duration.
Baseline (single assessment)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Hand Grip Strength
Lasso di tempo: Baseline (single assessment)
Maximum isometric hand grip strength will be assessed using a calibrated hand dynamometer. Three consecutive measurements will be obtained from the affected upper extremity with standardized positioning, and the highest value (kg) will be used for analysis.
Baseline (single assessment)
Upper Extremity Function
Lasso di tempo: Baseline (single assessment)
Upper extremity disability and symptoms will be evaluated using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. Scores range from 0 to 100, with higher scores indicating greater disability.
Baseline (single assessment)
Shoulder Pain Intensity
Lasso di tempo: Baseline (single assessment)
Shoulder pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain.
Baseline (single assessment)
Symptom Duration
Lasso di tempo: Baseline
Symptom duration will be recorded in months based on participant self-report and clinical history. Participants with rotator cuff-related shoulder pain will be categorized into groups according to symptom duration for comparative analyses.
Baseline
Shoulder Proprioception
Lasso di tempo: Baseline
Shoulder joint position sense (JPS) will be assessed using a laser pointer repositioning test. Repositioning error will be recorded in centimeters, with greater deviation indicating poorer proprioceptive accuracy.
Baseline

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

18 luglio 2026

Completamento primario (Stimato)

18 dicembre 2026

Completamento dello studio (Stimato)

19 dicembre 2026

Date di iscrizione allo studio

Primo inviato

17 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

17 giugno 2026

Primo Inserito (Effettivo)

23 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

23 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

17 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • KAEÜFTR-4

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .